Synopsis: Bliss GVS Pharma Ltd Q1 revenue rose 13% to Rs. 207 Crores YoY, and net profit grew 167% to Rs. 44.4 Crores QoQ. The shares of a Small-Cap company, specializing in manufacturing, marketing, trading, and export of pharmaceutical formulations, jumped upto 17...
Synopsis: Unifi Capital acquired 72.4 lakh Marksans Pharma shares (1.6 percent stake) via BSE for nearly Rs. 167.6 crore, at an average price of Rs. 231.5 per share. During Tuesday’s trading session, shares of a company engaged in the research, manufacturing &...
Synopsis: Asston Pharmaceuticals Ltd saw a 2.65 percent decline in stock price despite a new order worth Rs. 6.52 crore order to supply pharmaceuticals products. The shares of a micro-cap pharmaceutical company have come into the spotlight following the announcement...
Synopsis: Aarti Drugs reported strong year-on-year growth in Q1 FY26, with net profit rising 63.6 percent. While sequential performance declined, strategic expansions and backward integration are underway. One of India’s key pharmaceutical API manufacturers was in...
Synopsis: Emcure Pharmaceuticals and Sanofi India have partnered for exclusive distribution and promotion of Sanofi’s oral anti-diabetic products in India, aiming to expand patients’ access while Sanofi continues manufacturing. During Thursday’s trading session,...
Synopsis: Sakar Healthcare has secured its 3rd and 4th EU approvals for oncology injections, namely Carboplatin and Docetaxel, approved in Bulgaria and Bosnia. This made the stock jump by 5% approximately today The shares of this leading pharmaceutical company are in...
Synopsis: Wockhardt is exiting the US generics market after sustained losses to focus on antibiotics and insulin biologics. This strategic shift aims to drive innovation, profitability, and long-term growth across global markets. During Monday’s trading session,...
Synopsis: The company’s subsidiary, IGI signed a $1.225 billion licensing deal with AbbVie for ISB 2001. Strong FY25 growth, global expansion, and return to profitability further boosted investor confidence. The shares of the prominent pharmaceutical company broke the...
During Wednesday’s trading session, shares of a global pharmaceutical company providing access to affordable and innovative medicines are in focus on the stock exchanges. The increased attention comes as the company is set to turn ex-dividend tomorrow, i.e., 10th...
Synopsis:Leading Indian pharma firm with strong global presence, growing OTC focus, and robust US pipeline. Backed by solid financials and expansions, it targets FY26–27 growth, with brokerages maintaining a bullish outlook. India’s pharmaceutical sector, valued at...
Best stock discovery tool with +130 filters, built for fundamental analysis. Profitability, Growth, Valuation, Liquidity, and many more filters. Search Stocks Industry-wise, Export Data For Offline Analysis, Customizable Filters.
